Literature DB >> 9246474

Neuregulins as potential drugs for neurological disorders.

M A Marchionni1, C J Kirk, I J Isaacs, C J Hoban, N K Mahanthappa, E S Anton, C Chen, F Wason, D Lawson, F P Hamers, P D Canoll, R Reynolds, B Cannella, D Meun, W F Holt, W D Matthew, L E Chen, W H Gispen, C S Raine, J L Salzer, D I Gwynne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 9246474

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  3 in total

1.  Regulation of neuregulin expression in the injured rat brain and cultured astrocytes.

Authors:  Y Tokita; H Keino; F Matsui; S Aono; H Ishiguro; S Higashiyama; A Oohira
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

2.  Rapid axoglial signaling mediated by neuregulin and neurotrophic factors.

Authors:  Raymond M Esper; Jeffrey A Loeb
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

3.  The neuregulin, glial growth factor 2, diminishes autoimmune demyelination and enhances remyelination in a chronic relapsing model for multiple sclerosis.

Authors:  B Cannella; C J Hoban; Y L Gao; R Garcia-Arenas; D Lawson; M Marchionni; D Gwynne; C S Raine
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.